The APOE ε4 has been identified as the most significant genetic risk factor associated with AD11 and other neurodegenerative diseases, including frontotemporal lobar dementia (FTLD), Lewy body dementia (LBD), and other amyloid‐beta (Aβ) and tau pathologies.12 Here, APOE is linked to neurodegenerative disease.